Lakefront Biotherapeutics NV 20-F for FY2022
Lakefront Biotherapeutics NV (LKFT)
20-F
2023-03-23
For: 2022-12-31
View Original
Added on
April 04, 2026
About this 20-F
Lakefront Biotherapeutics NV filed this 20-F on March 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 505.28M EUR
- up 4.2% from 484.85M EUR a year earlier
- Net loss
- 217.99M EUR
- compared with a net loss of 103.23M EUR a year earlier
- Diluted EPS
- -3.32 EUR
- compared with -1.58 EUR a year earlier